Theriva Biologics TOVX Q4 2024 Annual earnings
Reported March 6, 2025 · Before market open
Revenue$154.0K
EPS-$3.30Beat by $3.06
EPS estimate-$6.36
Next report
Aug 12, 2026 (In 1 week)Revenue estimate$300.0K
EPS estimate-$0.06
Versus estimates
Revenue
Q1 2026$300.0KIn line
Q4 2024$154.0K
Diluted EPS
Ask the moment Theriva Biologics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Theriva Biologics report Q4 2024 earnings?
- Theriva Biologics (TOVX) reported Q4 2024 earnings on March 6, 2025 before market open.
- What were Theriva Biologics's Q4 2024 revenue and EPS?
- Theriva Biologics reported revenue of $154.0K and eps of $-3.30 for Q4 2024.
- Did Theriva Biologics beat estimates in Q4 2024?
- EPS beat the consensus estimate of $-6.36 by $3.06.
- Where can I find Theriva Biologics's Q4 2024 SEC filings?
- You can read the 10-K periodic report (0001410578-25-000285) directly on SEC EDGAR. The filing index links above go to sec.gov.